Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) SHH

37.22

+0.46(+1.25%)

Updated at August 19 11:29AM

Currency In CNY

Valuation

Market Cap8.08B
Enterprise Value8.96B
P/E Ratio-13.16
PEG Ratio1.56
Price/Sales Ratio85.04
Price/Book Ratio11.65
Enterprise/Revenue91.03
Enterprise/EBITDA-15.33

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-6.46
Operating Margin-6.38

Management Effectiveness

Return On Assets-0.27
Return On Equity-0.65

Income Statement

Revenue199.78M
Revenue/Share0.44
Gross Profit170.83M
EBITDA-836.27M
Net Income-1.04B
Diluted EPS-2.61

Balance Sheet

Total Cash1.13B
Total Cash/Share2.83
Total Debt2.17B
Total Debt/Equity1.7
Current Ratio0.94
Book Value Per Share3.16

Price History

52-Week Change60.22
52-Week High39.31
52-Week Low15.36
Moving Average 50 Days31.36
Moving Average 200 Days23.05

Statistics

Average Volume17.52M
Shares Outstanding399.6M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.07
Last Split FactorN/A
Last Split DateN/A